CoImmune is an immuno-oncology company developing two cellular platform technologies. The CAR-CIK technology is a variation on CAR-T therapy being developed for liquid tumors and the RNA-loaded dendritic cell technology is being developed for solid tumors.
Employment range in NC
Primary site activity
Potential end market(s)
Products under development
Clinical trials ongoing in ALL, NHL, CLL and advanced kidney cancer